Skip to main content
BetterLife Pharma logo

BetterLife Pharma — Investor Relations & Filings

Ticker · BETR ISIN · CA08772P2026 CSE Professional, scientific and technical activities
Open in API
Filings indexed 282 across all filing types
Latest filing 2023-03-11 Capital/Financing Update
Country CA Canada
Listing CSE BETR

About BetterLife Pharma

https://abetterlifepharma.com/

BetterLife Pharma is an emerging biotechnology company focused on developing and commercializing novel, patient-friendly compounds to treat neuro-psychiatric and neurological disorders, addressing significant unmet mental health needs. The company's core strategy involves revolutionizing brain health by producing non-hallucinogenic medicines. Its lead product candidate is 2-Bromo-LSD (BETR-001), a second-generation lysergic acid diethylamide (LSD) derivative. BETR-001 is designed to mimic the projected therapeutic properties of LSD, acting as a potent neuroplastogen, but without causing psychedelic effects or incurring the high regulatory hurdles associated with Schedule 1 controlled substances. BETR-001 is being developed as a potential therapy for debilitating conditions such as treatment-resistant depression, PTSD, anxiety, and cluster headaches.

Recent filings

Filing Released Lang Actions
News release (amended) - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the filing of an amended and restated offering document for a private placement of units by BetterLife Pharma Inc. It discusses the offering details, regulatory approvals, and use of proceeds. There is no financial data, no detailed financial report, no earnings information, no management discussion of results, no audit information, and no meeting materials. The document is primarily about a financing activity (private placement offering) and the filing of the related offering document. This fits the category of Capital/Financing Update (CAP). The document length is over 6,000 characters and contains substantive information about the offering, not just a brief announcement or link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the best classification is CAP with high confidence.
2023-03-11 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing the publication of promising preclinical study results for a drug candidate by BetterLife Pharma. It discusses scientific findings, therapeutic potential, and future clinical trial plans. There is no indication of financial data, regulatory filings, shareholder information, or corporate governance content. The document is not a financial report, earnings release, or regulatory filing. It is a corporate announcement about research progress and study publication, which does not fit into any of the specific financial or regulatory filing categories. Therefore, the best fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2023-03-09 English
Notice of meeting - English.pdf
AGM Information Classification · 100% confidence The document is a Notice of Annual General Meeting (AGM) of shareholders for BetterLife Pharma Inc. It provides details about the meeting date, time, location (conference call), agenda items including election of directors, appointment of auditor, and other business. It also includes voting instructions and proxy information. There is no financial data or report content included, only the notice and meeting logistics. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself. The document length is 4048 characters, which is consistent with a notice rather than a full report. Therefore, the correct classification is AGM Information (AGM-R).
2023-02-23 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is a form for shareholders to request receipt of Interim Financial Statements and Annual Financial Statements by mail or email. It does not contain any actual financial data, analysis, or report content. It is essentially a communication related to distribution of financial reports rather than the reports themselves. The document length is short (1364 characters) and it is a request form, not a report or announcement of results. Therefore, it fits best as a Regulatory Filing (RNS) since it does not meet criteria for any specific report type and is a miscellaneous regulatory communication.
2023-02-23 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for the Annual General Meeting (AGM) of BetterLife Pharma Inc. It includes instructions for shareholders to appoint a proxy to vote on their behalf at the AGM, details on voting methods, and voting recommendations for director elections, auditor appointment, and other matters. It is not the AGM presentation or materials themselves, but the proxy solicitation form related to the AGM. According to the filing definitions, this type of document is classified as Proxy Solicitation & Information Statement (PSI). The document length is about 5987 characters, which is consistent with a proxy form rather than a full AGM presentation or annual report. Therefore, the correct classification is PSI with high confidence.
2023-02-23 English
Management information circular - English.pdf
AGM Information Classification · 100% confidence The document is a Notice of Annual General Meeting (AGM) and an Information Circular related to the AGM of BetterLife Pharma Inc. It includes details about the meeting date, voting procedures, proxy solicitation, and shareholder information. It does not contain financial statements or detailed financial performance data itself but is related to the AGM process and materials shared with shareholders for the meeting. The presence of proxy information and meeting logistics confirms it is AGM-related material. Therefore, the document fits the category of AGM Information (AGM-R). The document length is substantial and contains detailed meeting and proxy information, not just a brief announcement, supporting this classification.
2023-02-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.